Neoplasms

Respiratory Tract (Lung and Bronchial) Diseases

All Conditions

Heart and Blood Diseases

Blood and Lymph Conditions

Immune System Diseases

Urinary Tract, Sexual Organs, and Pregnancy Conditions

Skin and Connective Tissue Diseases

Digestive System Diseases

Symptoms and General Pathology

Rare Diseases

Lung Neoplasms

Vascular Diseases

Multiple Myeloma

Neoplasms, Plasma Cell

Prostatic Neoplasms

Breast Neoplasms

Colorectal Neoplasms

Recurrence

Lymphoma

Leukemia

Thrombosis

Hemostatic Disorders

Blood Coagulation Disorders

Body Weight

Gastrointestinal Neoplasms

Intestinal Neoplasms

Lymphoproliferative Disorders

Myeloproliferative Disorders

Thromboembolism

Venous Thromboembolism

Venous Thrombosis

Urogenital Neoplasms

Digestive System Neoplasms

Lymphatic Diseases

Embolism

Embolism and Thrombosis

Lymphosarcoma

Chronic Myeloproliferative Disorders

Fibrinolytic Agents

Anticoagulants

All Drugs and Chemicals

Coagulants

Heparin

Hemostatics

Calcium heparin

Heparin, Low-Molecular-Weight

Tinzaparin

Dalteparin

Patients with objectively confirmed cancer associated venous thromboembolism receiving tinzaparin treatment to prevent recurrence of venous thromboembolism

Subcutaneous injection of 175 IU/kg once daily for 6 months

G Meyer, Professor

F Scotte, Dr

The purpose of this study is to validate the Ottawa score (risk of thromboembolic recurrences) in cancer patients with thromboembolic disease treated with tinzaparin (Innohep®)

The Ottawa score is a clinical predictive score aiming at stratifying thromboembolic recurrences in cancer patients according to identified clinical risk factors and histological type of the tumor. This score has never been validated externally in a prospective way in patients treated with tinzaparin. The objective of this observational prospective study is to enroll cancer patients with TED treated with tinzaparin for a planned period of 6 months and to collect data on thromboembolic recurrences, major hemorrhages, deaths and heparin-induced thrombocytopenia

Non Interventional Study of the Validation of the Ottawa Score in Cancer Patients With Venous Thromboembolism (VTE)

Prediction of Thromboembolic Recurrences in Cancer Patients With Venous Thromboembolic Disease (TED)

LEO Pharma

Infections

Gland and Hormone Related Diseases

Wounds and Injuries

Communicable Diseases

Intestinal Diseases

Aneurysm

Kidney Calculi

Nephrolithiasis

Calculi

Leiomyoma

Aortic Aneurysm

Gastrointestinal Diseases

Myofibroma

Diverticulitis

Pregnancy, Ectopic

Pancreatitis

Intraabdominal Infections

Gallstones

Cholelithiasis

Cholecystolithiasis

Cysts

Ovarian Cysts

Polyps

Appendicitis

Cardiac Complexes, Premature

Abdominal Injuries

Pancreatic Diseases

Aortic Diseases

Gastroenteritis

Cecal Diseases

Neoplasms, Connective and Soft Tissue

Neoplasms by Histologic Type

Kidney Diseases

Urologic Diseases

Urogenital Diseases

Female Urogenital Diseases

Pregnancy Complications

Female Urogenital Diseases and Pregnancy Complications

Urolithiasis

Urinary Calculi

Male Urogenital Diseases

Pathological Conditions, Anatomical

Diverticulum

Diverticular Diseases

Biliary Tract Diseases

Gallbladder Diseases

Ovarian Diseases

Adnexal Diseases

Genital Diseases, Female

Genital Diseases

Gonadal Disorders

Endocrine System Diseases

Subjects that present to the Emergency Department with complaints necessitating abdominal or pelvic imaging.

Duke employees that will voluntarily have an abdominal or pelvic ultrasound for with the sole purpose being for the study.

Joshua Broder, MD

Summary

1. Purpose and Objective: The purpose of this study is to test the feasibility of rapid acquisition of point of care 3D ultrasound in obtaining abdominal and/or pelvic images. The study will use a newly developed acquisition method and post-processing technique to create three dimensional image models of the abdomen and/or pelvis.
2. Study activities and population group. The study population will be a convenience sample of patients of any age presenting to the Emergency Department with complaints necessitating a clinical abdominal and/or pelvic imaging. The study intervention includes acquisition of research ultrasound images, which will not be used for clinical care, and comparison of these images with clinically obtained images. Other clinical data such as surgical and pathology reports will also be reviewed. 3.Data analysis and risk/safety issues. This is a pilot study intended to determine feasibility and to refine image reconstruction algorithms. Research images will be compared to clinical images. Comparison of research images with final diagnosis will also occur. The research intervention, an ultrasound exam, has no known safety risks. The only risk to subjects is loss of confidentiality.

This study is observational, not interventional, because the experimental ultrasound will be performed in all subjects and will not be used in the clinical care of patients (consequently, will not have the opportunity to affect clinical outcomes). Experimental images will be reviewed after completion of clinical care and will not be provided to the clinicians caring for the subjects. The investigators are not measuring the effect of the ultrasound examination on the subjects' outcomes.

Point of Care 3D Ultrasound for Various Applications: A Pilot Study

A Pilot Study to Test Rapid Acquisition of Point of Care Ultrasound for Various Applications

Wallace H. Coulter Foundation

Duke University

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Non Interventional Study of the Validation of the Ottawa Score in Cancer Patients With Venous Thromboembolism (VTE)	NCT03099031	Venous Thromboe...	Tinzaparin	18 Years -	LEO Pharma
Point of Care 3D Ultrasound for Various Applications: A Pilot Study	NCT02831556	Appendicitis Evidence of Cho... Gallstones Pregnancy, Ecto... Aortic Aneurysm Kidney Stones Intrauterine Pr... Diverticulitis Abdominal Injur... Tumors Pancreatitis Digestive Syste... Gastrointestina... Intraabdominal ... Intestinal Dise... Pregnancy Vascular Diseas... Uterine Fibroid... Ovarian Cysts Uterine Abnomin... Bladder Abnomin... Testicular Abno... Polyps		-	Duke University

Spots Global Cancer Trial Database for vascular disease